Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Lantern Pharma Inc. (NASDAQ:LTRN) (“Lantern”, the “Company” or “we”), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, today announced the closing of its previously announced registered direct offering of 3,669,725…
The company expects about $4 million in upfront gross proceeds and up to an additional $4 million if warrants are fully exercised. It plans to use net proceeds for working capital and other general corporate purposes.